tiprankstipranks
Advertisement
Advertisement

RGNX Stock Latest News

RegenXbio’s RGX-202 Pivotal Win Lifts Outlook
Company AnnouncementsRegenXbio’s RGX-202 Pivotal Win Lifts Outlook
13h ago
RGNX
RegenXBio’s Earnings Call Signals Pivotal Gene-Therapy Win
PremiumCompany Announcements
RegenXBio’s Earnings Call Signals Pivotal Gene-Therapy Win
2d ago
RGNX
Regenxbio price target lowered to $16 from $17 at Morgan Stanley
PremiumThe Fly
Regenxbio price target lowered to $16 from $17 at Morgan Stanley
5d ago
RGNX
Regenxbio price target lowered to $14 from $25 at BofA
PremiumThe Fly
Regenxbio price target lowered to $14 from $25 at BofA
5d ago
RGNX
Regenxbio price target lowered to $12 from $37 at Barclays
PremiumThe Fly
Regenxbio price target lowered to $12 from $37 at Barclays
5d ago
RGNX
Midday Fly By: Cisco reports Q3 beat, Chinese firms cleared to buy Nvidia chips
PremiumThe FlyMidday Fly By: Cisco reports Q3 beat, Chinese firms cleared to buy Nvidia chips
6d ago
AEM
FNV
Regenxbio reports Q1 EPS ($1.72) vs. 12c last year
Premium
The Fly
Regenxbio reports Q1 EPS ($1.72) vs. 12c last year
6d ago
RGNX
Regenxbio expects cash, equivalents to fund operations into early 2027
Premium
The Fly
Regenxbio expects cash, equivalents to fund operations into early 2027
6d ago
RGNX
Regenxbio’s RGX-202 shows efficacy in Phase 3 Duchenne trial
PremiumThe Fly
Regenxbio’s RGX-202 shows efficacy in Phase 3 Duchenne trial
6d ago
RGNX
RegenXBio Advances RGX-202 With Positive Phase III Results
PremiumCompany Announcements
RegenXBio Advances RGX-202 With Positive Phase III Results
6d ago
8K
RGNX
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
PremiumThe Fly
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
8d ago
AZN
BMY
Trump Trade: U.S. plans AI security order without required model tests
PremiumThe Fly
Trump Trade: U.S. plans AI security order without required model tests
9d ago
DYN
RNA
Trump approves plan to fire FDA head Marty Makary, CBS reports
PremiumThe FlyTrump approves plan to fire FDA head Marty Makary, CBS reports
9d ago
DYN
RNA
RGNX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
RGNX Upcoming Earnings Report: What to Expect?
16d ago
RGNX
Private Markets: Cursor in talks for $2B, Blue Energy secures $380M
Premium
The Fly
Private Markets: Cursor in talks for $2B, Blue Energy secures $380M
27d ago
BA
BE
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
PremiumThe Fly
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
1M ago
DYN
RNA
Shareholders Sue RGNX Over Gene Therapy Study Claims
PremiumMarket News
Shareholders Sue RGNX Over Gene Therapy Study Claims
2M ago
RGNX
RegenXBio Reaches Settlement with GSK Over License Fees
PremiumCompany Announcements
RegenXBio Reaches Settlement with GSK Over License Fees
2M ago
8K
RGNX
REGENXBIO Faces Federal Securities Lawsuit Over Allegedly Concealed Gene Therapy Safety Risks
PremiumClass Action
REGENXBIO Faces Federal Securities Lawsuit Over Allegedly Concealed Gene Therapy Safety Risks
2M ago
RGNX
Regenxbio reports interim data from Phase I/II AFFINITY DUCHENNE trial
PremiumThe FlyRegenxbio reports interim data from Phase I/II AFFINITY DUCHENNE trial
2M ago
RGNX
Regenxbio price target lowered to $30 from $32 at H.C. Wainwright
Premium
The Fly
Regenxbio price target lowered to $30 from $32 at H.C. Wainwright
2M ago
RGNX
Controversial Prasad leaving FDA, NYT reports
Premium
The Fly
Controversial Prasad leaving FDA, NYT reports
2M ago
AZN
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >